acetylcysteine has been researched along with Nevi, Melanocytic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boucher, KM; Cassidy, PB; Florell, SR; Grossman, D; Honeggar, M; Leachman, SA; Liu, T | 1 |
Boucher, KM; Cassidy, P; Cotter, MA; Florell, SR; Goodson, AG; Grossman, D; Liu, T; Wade, M | 1 |
1 trial(s) available for acetylcysteine and Nevi, Melanocytic
Article | Year |
---|---|
A Phase II Randomized Placebo-Controlled Trial of Oral N-acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress In Vivo.
Topics: Acetylcysteine; Administration, Oral; Antioxidants; Biomarkers; Double-Blind Method; Glutamate-Cysteine Ligase; Guanine; Humans; Melanoma; Mutation; Nevus, Pigmented; Oxidative Stress; Pilot Projects; Receptor, Melanocortin, Type 1; Skin Neoplasms; Sunlight; Thioredoxin Reductase 1; Ultraviolet Rays | 2017 |
1 other study(ies) available for acetylcysteine and Nevi, Melanocytic
Article | Year |
---|---|
Use of oral N-acetylcysteine for protection of melanocytic nevi against UV-induced oxidative stress: towards a novel paradigm for melanoma chemoprevention.
Topics: Acetylcysteine; Administration, Oral; Adult; Aged; Anticarcinogenic Agents; Antioxidants; Cysteine; Female; Glutathione; Humans; Male; Melanoma; Middle Aged; Nevus, Pigmented; Oxidative Stress; Risk; Skin Neoplasms; Time Factors; Ultraviolet Rays | 2009 |